While there are many different size clinical research sites, competition becomes increasingly difficult for smaller sites with smaller amounts of employees, resources, etc.. In a recent article written by Gina Nesbit, a hypothetical site is created, Acme Research,...
Although the elderly are often considered ineligible for clinical trials, experts in a recent article from Outsourcing-pharma.com are saying the age group “must be taken into consideration more often during research.” Clinical trials are intended to be...
Effective September 26,2012 Health and Human Services has assigned responsibility to FDA for enforcing reporting by sponsors on ClinicalTrials.gov. Based on a notice by the Federal Register, FDA is now responsible for keeping track of the database’s most recent...
TransCelerate BioPharma which is an intriguing new big pharma collaboration was recently launched at a US trade show with the intentions of expediting the clinical research process. According to a recent article from Outsourcing-pharma.com , there are “five...
Researchers are determining that simply not having enough participants to fill a clinical trial is not enough-diversity is an essential element in research trials. Electra Paskett, co-director of the Diversity Enhancement Program at the Arthur G. James Cancer Hospital...
A study published in the Journal of the American Medical Informatics Association analyzed whether people were more inclined to develop blood clots in the arms and legs depending on their height and weight. The team of researchers at MetroHealth Medical Center and...
